Evidence map›Paper›PMID 28356354›Full record

ArticleThe Journal of biological chemistry2017

N-terminal half of transportin SR2 interacts with HIV integrase.

Vicky G Tsirkone, Jolien Blokken, Flore De Wit, Jolien Breemans, Stéphanie De Houwer, Zeger Debyser, Frauke Christ, Sergei V Strelkov

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Vicky G TsirkoneFrom the Laboratory for Biocrystallography and.ORCID 0000-0002-6452-1871
Jolien Blokkenthe Laboratory for Molecular Virology and Gene Therapy, KU Leuven, 3000 Leuven, Belgium.
Flore De Witthe Laboratory for Molecular Virology and Gene Therapy, KU Leuven, 3000 Leuven, Belgium.
Jolien BreemansFrom the Laboratory for Biocrystallography and.
Stéphanie De Houwerthe Laboratory for Molecular Virology and Gene Therapy, KU Leuven, 3000 Leuven, Belgium.
Zeger Debyserthe Laboratory for Molecular Virology and Gene Therapy, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-3982-1565
Frauke Christthe Laboratory for Molecular Virology and Gene Therapy, KU Leuven, 3000 Leuven, Belgium.
Sergei V StrelkovFrom the Laboratory for Biocrystallography and sergei.strelkov@kuleuven.be.ORCID 0000-0001-7189-4652
Rega Institute for Medical Research · BEInstitute of Crystallography · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The karyopherin transportin SR2 (TRN-SR2, TNPO3) is responsible for shuttling specific cargoes such as serine/arginine-rich splicing factors from the cytoplasm to the nucleus. This protein plays a key role in HIV infection by facilitating the nuclear import of the pre-integration complex (PIC) that contains the viral DNA as well as several cellular and HIV proteins, including the integrase. The process of nuclear import is considered to be the bottleneck of the viral replication cycle and therefore represents a promising target for anti-HIV drug design. Previous studies have demonstrated that the direct interaction between TRN-SR2 and HIV integrase predominantly involves the catalytic core domain (CCD) and the C-terminal domain (CTD) of the integrase. We aimed at providing a detailed molecular view of this interaction through a biochemical characterization of the respective protein complex. Size-exclusion chromatography was used to characterize the interaction of TRN-SR2 with a truncated variant of the HIV-1 integrase, including both the CCD and CTD. These experiments indicate that one TRN-SR2 molecule can specifically bind one CCD-CTD dimer. Next, the regions of the solenoid-like TRN-SR2 molecule that are involved in the interaction with integrase were identified using AlphaScreen binding assays, revealing that the integrase interacts with the N-terminal half of TRN-SR2 principally through the HEAT repeats 4, 10, and 11. Combining these results with small-angle X-ray scattering data for the complex of TRN-SR2 with truncated integrase, we propose a molecular model of the complex. We speculate that nuclear import of the PIC may proceed concurrently with the normal nuclear transport.

Indexed as

HIV InfectionsModels, MolecularActive Transport, Cell NucleusAnti-HIV Agentsbeta KaryopherinsCell NucleusDrug DesignHIV-1HIV IntegraseHumansProtein DomainsRepetitive Sequences, Amino AcidX-Ray DiffractionAnti-HIV Agentsbeta KaryopherinsHIV IntegraseTNPO3 protein, humanhost-pathogen interactionhuman immunodeficiency virus (HIV)integrasenuclear transportprotein-protein interactionsmall-angle X-ray scattering (SAXS)transportin SR2

Identifiers

PMID28356354
PMCPMC5465493
OpenAlexW2602780901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.